Nagendran Sukumar's Form 4 filing
Taysha Gene Therapies, Inc. (TSHA) · filed Jan 14, 2026
- Accession no.
- 0001665124-26-000002
- Filed
- Jan 14, 2026
- Trade date
- Jan 12, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $942.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nagendran SukumarCIK 0001665124 | Director, Officer (President and Head of R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Common Stock | MOption exerciseAcquired | +111,324 | $0.70 | +$77,926.8 | 1,117,763 | Direct | |
| Jan 12, 2026 | Common Stock | MOption exerciseAcquired | +88,676 | $1.71 | +$151,635.96 | 1,206,439 | Direct | |
| Jan 12, 2026 | Common Stock | SSaleDisposed | −200,000 | $4.71 | −$942,000 | 1,006,439 | Direct | |
| Jan 12, 2026 | Common Stock | AGrant or awardAcquired | +427,000 | $0.00 | $0 | 1,433,439 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Common Stock | MOption exerciseDisposed | −111,324 | $0.00 | $0 | 111,359 | Direct | |
| Jan 12, 2026 | Common Stock | MOption exerciseDisposed | −88,676 | $0.00 | $0 | 474,941 | Direct | |
| Jan 12, 2026 | Common Stock | AGrant or awardAcquired | +274,000 | $0.00 | $0 | 274,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.